Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

DLRHX vs. ETHSX: which is better?

Bottom line

DLRHX vs ETHSX: the short answer

DLRHX (Nomura Healthcare Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both mutual funds.

But DLRHX is far broader, holding 108 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.

ETHSX is cheaper at 1.18% vs 1.46% — a difference of $28 a year per $10,000 invested.

Over five years, DLRHX returned +7.2% a year vs +5.3% for ETHSX (reporting dates differ).

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

DLRHX vs ETHSX side by side

DLRHXETHSX
TypeMutual fundMutual fund
Fund familyVoyaMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.46%1.18%
Annual cost per $10k$146$118
10-yr cost on $10k (prospectus)$1,797$1,911
Max front load0%5.25%
12b-1 fee0.5%0.25%
1-yr return+21.8%−1.9%
5-yr return (annualized)+7.2%+5.3%
10-yr return (annualized)+9.9%+6.4%
Best quarter—+14.2%
Worst quarter—−12.1%
Net assets (fund)$750.2M$757.9M
Number of holdings10842
Portfolio turnover4%3%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

10 of DLRHX's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingDLRHXETHSX
Abbvie Inc4.19%6.46%
Eli Lilly & Company4.16%12.47%
Unitedhealth Group Inc3.88%5.49%
Merck & Company Inc3.68%5.08%
Gilead Sciences Inc3.54%3.34%
Astrazeneca Plc3.27%6.24%
Roche Holding Ag3.01%5.44%
Vertex Pharmaceuticals Inc1.66%3.38%
Neurocrine Biosciences Inc1.57%1.41%
Boston Scientific Corp1.42%2.18%

Source: SEC Form N-PORT

DLRHX top 10

  1. Ucb Sa — 5.19%
  2. Abbvie Inc — 4.19%
  3. Eli Lilly & Company — 4.16%
  4. Regeneron Pharmaceuticals Inc — 3.91%
  5. Unitedhealth Group Inc — 3.88%
  6. Pfizer Inc — 3.84%
  7. Merck & Company Inc — 3.68%
  8. Gilead Sciences Inc — 3.54%
  9. Astrazeneca Plc — 3.27%
  10. Elevance Health Inc — 3.25%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between DLRHX and ETHSX?
DLRHX (Nomura Healthcare Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both mutual funds. But DLRHX is far broader, holding 108 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
Which is cheaper, DLRHX or ETHSX?
ETHSX has the lower expense ratio (1.18%).
Should I own both DLRHX and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.